RE:RE:RE:So Far the TLT Phase 1 Trial Has been Completely SuccessfulThe fact that the share price has been cut in half is like Eogan---- claims, "a shame". More than that, it is absolutely stupid. The initial 3 patient study was designed to measure safety & tolerability. It was successfully completed and those results vetted by the Data Safety Monitoring Board. More than that, the doctors that did comment on it were "pleased" with the results, and the share price gets cut in half??? This doesn't make any sense. The price went down and continues to do so. People are upset with the CEO. What is he supposed to do until the afore mentioned "Board", informs him of the latest trial results, make up something to say? It would be foolish for him come out with some type of PR until he has something definitive or informative to say. We are in the middle of the second part of Ph 1 with 6 patients being treated at therapeutic dose. I believe when RW is informed of something worth-while he will put out a PR as he has in the past.